Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- previous diagnosis of COVID-19 or history of suspected acute COVID-19 illness
Outros fatores diagnósticos
- fatigue/weakness
- cognitive impairment (brain fog)
- impaired sleep
- headache
- dizziness
- dyspnea
- cough
- anosmia/dysgeusia
- pain (including arthralgias and myalgias)
- chest pain
- postexertional malaise
- anxiety/depression
- palpitations
- thirst/dry mouth
- loss of sexual drive or capacity
- numbness/tingling
- hair loss
- gastrointestinal symptoms
Fatores de risco
- severe COVID-19 illness (requiring hospitalization or ICU admission)
- not vaccinated or only partially vaccinated against COVID-19
- female sex
- age >40 years
- BMI >30 kg/m²
- smoking
- anxiety/depression
- asthma
- chronic kidney disease
- chronic obstructive pulmonary disease (COPD)
- diabetes
- immunosuppression
- ischemic heart disease
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- clinical diagnosis
- complete blood count
- comprehensive metabolic panel
- creatine kinase
- C-reactive protein
- erythrocyte sedimentation rate
- serum ferritin level
- thyroid function tests
- serum 25-hydroxy vitamin D
- pulse oximetry
Investigações a serem consideradas
- orthostatic testing-tilt table testing
- electrocardiogram
- pulmonary function testing
- chest radiograph
- chest CT
- B-type natriuretic peptide
- D-dimer
- antinuclear antibody
- rheumatoid factor
- anti-cyclic citrulinated peptide
- serum vitamin B12
- blood thiamine
- serum folate
- plasma homocysteine
- high sensitivity troponin
- transthoracic echocardiogram
- ambulatory cardiac monitoring
- cardiac stress test
- cardiopulmonary exercise test
- cardiac MRI
- autonomic function testing
- overnight sleep study
- MRI head
- neuropsychological testing
Algoritmo de tratamento
all patients
Colaboradores
Autores
Benjamin Abramoff, MD, MS
Assistant Professor of Physical Medicine and Rehabilitation
Perelman School of Medicine
University of Pennsylvania
Philadelphia
PA
Declarações
BA has served on medical advisory boards regarding long COVID for Pfizer, Axcella Pharmaceutical, AstraZeneca, Intrivo Diagnostics, and UnitedHealthcare. BA is an author of references cited in this topic.
Shawn Joshi, MD, PhD
Clinical Resident of Physical Medicine & Rehabilitation
Spaulding Rehabilitation Hospital
Clinical Fellow in Medicine
Harvard Medical School
Boston
MA
Declarações
SJ declares that he has no competing interests.
Eric Herman, MD
Assistant Professor of Family Medicine
School of Medicine
Oregon Health and Science University
Portland
OR
Declarações
EH speaks on evaluation and management of Long COVID nationally. EH is developing educational material for the AAFP. EH has published other manuscripts as part of his current academic role with other leading medical publications.
Agradecimentos
Dr Benjamin Abramoff, Dr Shawn Joshi, and Dr Eric Herman would like to gratefully acknowledge Dr Julie Silver, a previous contributor to this topic.
Declarações
JS has participated in research funded by NIH and foundations on topics not related to COVID-19 including culinary medicine, prehabilitation, and chronic pain. JS is author of references cited in this topic.
Revisores
Sarah Jolley, MD, MSc
Associate Professor
Division of Pulmonary Sciences and Critical Care Medicine
University of Colorado
Denver
CO
Declarações
SJ receives NIH funding for work related to long COVID via the RECOVER consortium and AHRQ related to long COVID care delivery.
Trisha Greenhalgh, MA, MD, FRCP, FRCGP, FFPH, PhD
Professor of Primary Care Health Sciences
University of Oxford
Oxford
UK
Declarações
TG is an author of references cited in this topic.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing the long-term effects of COVID-19. January 2024 [internet publication].Texto completo
Centers for Disease Control and Prevention. COVID-19: clinical overview of long COVID. Feb 2025 [internet publication].Texto completo
Yelin D, Moschopoulos CD, Margalit I, et al. ESCMID rapid guidelines for assessment and management of long COVID. Clin Microbiol Infect. 2022 Jul;28(7):955-72.Texto completo Resumo
US Department of Veterans Affairs. Whole health system approach to long COVID: specialty care (nervous system). Sep 2024 [internet publication].Texto completo
US Department of Veterans Affairs. Whole health system approach to long COVID. August 2022 [internet publication].Texto completo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.

დიფერენციული დიაგნოზები
- Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
- Post-intensive care syndrome
- Postural orthostatic tachycardia syndrome (POTS)
Mais დიფერენციული დიაგნოზებიგაიდლაინები
- Clinical overview of long COVID
- COVID-19 rapid guideline: managing the long-term effects of COVID-19
Mais გაიდლაინებიპაციენტის ბროშურები
Anxiety: what are the treatment options?
COVID-19 (coronavirus)
მეტი პაციენტის ბროშურებიშედით სისტემაში ან გამოიწერეთ BMJ Best Practice
ამ მასალის გამოყენება ექვემდებარება ჩვენს განცხადებას